Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses

Autor: Tom Mariën, Bert Seys, Gabriele Braun, K. Hellmann, Edouard Adriaensen, Jan H. Spaas, Marc Suls, Lore Van Hecke, Sarah Broeckx, Jeroen Declercq, Aurélie Vandenberghe
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
Male
Pathology
Disease
Osteoarthritis
PLATELET-RICH PLASMA
Injections
Intra-Articular

0302 clinical medicine
allogeneic
Hematology
Allografts
Clinical Trial
horse
medicine.anatomical_structure
Lameness
Female
Joint Diseases
REPEATABILITY
arthrosis
medicine.medical_specialty
BONE-MARROW
Biology
Mesenchymal Stem Cell Transplantation
IMMUNOMODULATORY PROPERTIES
CLINICAL-TRIAL
SUBJECTIVE EVALUATION
MSC
03 medical and health sciences
field trial
Double-Blind Method
Internal medicine
medicine
INTRAARTICULAR INJECTION
Animals
Veterinary Sciences
Horses
Mesenchymal stem cell
Mesenchymal Stem Cells
Cell Biology
Chondrogenesis
medicine.disease
GCP
MODEL
030104 developmental biology
OSTEOARTHRITIS
Platelet-rich plasma
LAMENESS
Horse Diseases
Bone marrow
human activities
030217 neurology & neurosurgery
Developmental Biology
Follow-Up Studies
Zdroj: Stem Cells and Development
STEM CELLS AND DEVELOPMENT
ISSN: 1557-8534
1547-3287
Popis: Degenerative joint disease is one of the main causes of equine early retirement from pleasure riding or a performance career. The disease is initially triggered by an abnormal loading of normal cartilage or a normal loading of abnormal cartilage. This primary insult is accompanied with joint inflammation, which leads to further progressive degeneration of the articular cartilage and changes in the surrounding tissues. Therefore, in search for an effective treatment, 75 adult horses with early signs of degenerative fetlock joint disease were enrolled in a randomized, multicenter, double-blinded, and placebo-controlled study. Fifty animals were injected intra-articularly with the investigational veterinary product (IVP) consisting of allogeneic chondrogenic induced mesenchymal stem cells (ciMSCs) with equine allogeneic plasma, and 25 horses were injected with 0.9% NaCl (saline) control product. From week 3 to 18 after treatment, lameness scores (P
Databáze: OpenAIRE